Danimer Scientific和Chevron Phillips Chemical扩大合作，包括Rinnovo的应用开发™ 聚合物-动脉网

Danimer Scientific and Chevron Phillips Chemical Expand Collaboration to Include Application Development for Rinnovo™ Polymers

biospace 等信源发布 2023-09-20 07:00



可切换为仅中文







Collaboration to explore several high-volume polymer applications, taking advantage of cost and performance of Rinnovo™ materials

利用Rinnovo的成本和性能，合作探索几种高容量聚合物应用™ 材料

BAINBRIDGE, Ga.--(BUSINESS WIRE)-- Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process..

班布里奇，Ga。-Danimer Scientific，Inc。（NYSE:DNMR）（“Danimer”或“Company”），一家领先的下一代生物塑料公司，专注于生物降解材料的开发和生产，今天宣布正在扩大与Chevron Phillips Chemical（“CPChem”）的合作，探索铸造挤出薄膜的开发和商业化，使用Rinnovo吹塑挤出薄膜，注塑零件和旋转成型零件™ 在循环浆料反应器过程中生产的聚合物。。

Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics. The collaboration expands on Danimer and CPChem’s previously announced agreement, in which Danimer is evaluating the use of CPChem’s loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo™..

从头开始™ 是一种由Danimer专有的Novo22生产的内酯合成的聚羟基链烷酸酯（“PHA”）™ 催化剂技术，可用于生产传统塑料的可生物降解替代品。该合作扩展了Danimer和CPChem先前宣布的协议，其中Danimer正在评估CPChem的循环浆料反应器设计在Rinnovo制造过程中开发连续反应器系统的用途™..

Stephen E. Croskrey, chief executive officer of Danimer, said, “Our business relationship with CPChem continues to yield results, and we’re excited for the further opportunities that lie ahead. CPChem’s Research and Technology lab in Bartlesville, Oklahoma, is a premier facility staffed with world-class talent that we believe will accelerate the path toward adoption of Rinnovo™ materials in high-volume applications that will assist in lowering the cost to serve key markets.”.

Danimer首席执行官Stephen E.Croskrey说：“我们与CPChem的业务关系继续取得成果，我们对未来的进一步机遇感到兴奋.CPChem在俄克拉荷马州巴特尔斯维尔的研究与技术实验室是一家总理设施配备了世界级人才，我们相信这将加速采用Rinnovo的道路™ 大批量应用中的材料将有助于降低服务关键市场的成本。”。

Opened in 1950 by Phillips 66, CPChem’s Bartlesville facility contains first-class research equipment allowing for rapid testing of products across various processing conditions. Additionally, the facility’s testing and analytical capabilities provide a more rapid feedback loop, accelerating the development and optimization of resin formulations..

CPChem的Bartlesville工厂于1950年由Phillips 66开设，拥有一流的研究设备，可在各种加工条件下快速测试产品。此外，该设施的测试和分析能力提供了更快速的反馈回路，加速了树脂配方的开发和优化。。

“We continue to be excited about the potential of our MarTECH® process technology and related collaborations to advance Danimer’s Rinnovo™, another CPChem initiative that can help accelerate change for a more sustainable future,” said Venki Chandrashekar, CPChem vice president of research and technology..

“我们继续对MarTECH®工艺技术和相关合作的潜力感到兴奋，以推动Danimer的创新™, CPChem研究与技术副总裁Venki Chandrashekar说，另一项CPChem计划可以帮助加速变革，实现更可持续的未来。。

For more information on Danimer Scientific, visit www.DanimerScientific.com.

有关Danimer Scientific的更多信息，请访问www.danimerscific.com。

About Danimer Scientific

关于Danimer Scientific

Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day.

Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations.

其生物聚合物的应用包括添加剂，水性涂层，纤维，长丝，薄膜和注塑制品等。Danimer在20多个国家拥有430多项已授予专利和正在申请的专利，用于一系列制造工艺和生物聚合物配方。

For more information, visit www.DanimerScientific.com..

欲了解更多信息，请访问www.DanimerScientific.com。。

Forward‐Looking Statements

前瞻性陈述

Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

请注意，在本新闻稿中，我们可能会使用“出现”，“预期”，“相信”，“计划”，“期望”，“意图”，“未来”等词语，这些词语构成前瞻性陈述，其含义为1995年“私人证券诉讼改革法”安全港条款。

Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements.

前瞻性陈述是基于我们对影响公司的未来事件的期望和信念，因此涉及许多风险和不确定性。我们提醒说，前瞻性陈述不可保证，实际结果可能与前瞻性陈述中表达或暗示的实际结果大不相同。

Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company’s exposure to product liability or product warranty claims and other loss contingencies; disruption.

可能导致本公司运营或财务状况实际结果与本版本前瞻性声明所表达或暗示的潜在风险和不确定性包括但不限于消费者对我们的整体需求水平产品；一般经济状况和影响消费者信心，偏好和行为的其他因素；全球货币，资本和信贷市场的破坏和波动；公司客户的财务实力；公司实施其业务战略的能力，包括但不限于其扩展生产设施和工厂以满足客户对其产品及其时间的需求的能力；与公司预计财务信息不确定性有关的风险；公司执行和整合收购的能力；与我们产品有关的政府法规，立法或舆论的变化；本公司暴露于产品责任或产品保修索赔和其他损失突发事件；中断。

View source version on businesswire.com: https://www.businesswire.com/news/home/20230919746243/en/

在businesswire.com上查看源版本：https://www.businesswire.com/news/home/20230919746243/en/

Contacts

联络

Investors

投资者

James Palczynski

James Palczynski先生

ir@danimer.com

415-876-8429

Media

媒体